Search Results - Lantero‐Rodriguez, Juan

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

    Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers by Camporesi, Elena, Lashley, Tammaryn, Gobom, Johan, Lantero-Rodriguez, Juan, Hansson, Oskar, Zetterberg, Henrik, Blennow, Kaj, Becker, Bruno

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Truncating tau reveals different pathophysiological actions of oligomers in single neurons

    Truncating tau reveals different pathophysiological actions of oligomers in single neurons by Hill, Emily, Karikari, Thomas K., Lantero-Rodriguez, Juan, Zetterberg, Henrik, Blennow, Kaj, Richardson, Magnus J., Wall, Mark J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy

    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy by Grothe, Michel J., Moscoso, Alexis, Ashton, Nicholas J., Karikari, Thomas K., Lantero-Rodriguez, Juan, Snellman, Anniina, Zetterberg, Henrik, Blennow, Kaj, Schöll, Michael

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

    Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease by Moscoso, Alexis, Grothe, Michel J., Ashton, Nicholas J., Karikari, Thomas K., Lantero Rodríguez, Juan, Snellman, Anniina, Suárez-Calvet, Marc, Blennow, Kaj, Zetterberg, Henrik, Schöll, Michael

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

    Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline by Lantero Rodriguez, Juan, Karikari, Thomas K., Suárez-Calvet, Marc, Troakes, Claire, King, Andrew, Emersic, Andreja, Aarsland, Dag, Hye, Abdul, Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration

    Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration by Ashton, Nicholas J., Suárez‐Calvet, Marc, Karikari, Thomas K., Lantero‐Rodriguez, Juan, Snellman, Anniina, Sauer, Mathias, Simrén, Joel, Minguillon, Carolina, Fauria, Karine, Blennow, Kaj, Zetterberg, Henrik

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

    Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative by Zettergren, Anna, Lord, Jodie, Ashton, Nicholas J., Benedet, Andrea L., Karikari, Thomas K., Lantero Rodriguez, Juan, Snellman, Anniina, Suárez-Calvet, Marc, Proitsi, Petroula, Zetterberg, Henrik, Blennow, Kaj

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

    Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change by Smirnov, Denis S., Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik, Simrén, Joel, Lantero-Rodriguez, Juan, Karikari, Thomas K., Hiniker, Annie, Rissman, Robert A., Salmon, David P., Galasko, Douglas

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin

    AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin by Börgeson, Emma, Wallenius, Ville, Syed, Gulam H., Darshi, Manjula, Lantero Rodriguez, Juan, Biörserud, Christina, Ragnmark Ek, Malin, Björklund, Per, Quiding-Järbrink, Marianne, Fändriks, Lars, Godson, Catherine, Sharma, Kumar

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis

    Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis by Karikari, Thomas K., Emeršič, Andreja, Vrillon, Agathe, Lantero‐Rodriguez, Juan, Ashton, Nicholas J., Kramberger, Milica Gregorič, Dumurgier, Julien, Hourregue, Claire, Čučnik, Saša, Brinkmalm, Gunnar, Rot, Uroš, Zetterberg, Henrik, Paquet, Claire, Blennow, Kaj

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

    Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology by Ashton, Nicholas J., Pascoal, Tharick A., Karikari, Thomas K., Benedet, Andréa L., Lantero-Rodriguez, Juan, Brinkmalm, Gunnar, Snellman, Anniina, Schöll, Michael, Troakes, Claire, Hye, Abdul, Gauthier, Serge, Vanmechelen, Eugeen, Zetterberg, Henrik, Rosa-Neto, Pedro, Blennow, Kaj

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease

    Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease by Ashton, Nicholas J., Benedet, Andréa L., Pascoal, Tharick A., Karikari, Thomas K., Lantero-Rodriguez, Juan, Brum, Wagner S., Mathotaarachchi, Sulantha, Therriault, Joseph, Savard, Melissa, Chamoun, Mira, Stoops, Erik, Francois, Cindy, Vanmechelen, Eugeen, Gauthier, Serge, Zimmer, Eduardo R., Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

    The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease by Simrén, Joel, Leuzy, Antoine, Karikari, Thomas K., Hye, Abdul, Benedet, Andréa Lessa, Lantero‐Rodriguez, Juan, Mattsson‐Carlgren, Niklas, Schöll, Michael, Mecocci, Patrizia, Vellas, Bruno, Tsolaki, Magda, Kloszewska, Iwona, Soininen, Hilkka, Lovestone, Simon, Aarsland, Dag, Hansson, Oskar, Rosa‐Neto, Pedro, Westman, Eric, Blennow, Kaj, Zetterberg, Henrik, Ashton, Nicholas J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease

    P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease by Lantero‐Rodriguez, Juan, Snellman, Anniina, Benedet, Andrea L, Milà‐Alomà, Marta, Camporesi, Elena, Montoliu‐Gaya, Laia, Ashton, Nicholas J, Vrillon, Agathe, Karikari, Thomas K, Gispert, Juan Domingo, Salvadó, Gemma, Shekari, Mahnaz, Toomey, Christina E, Lashley, Tammaryn L, Zetterberg, Henrik, Suárez‐Calvet, Marc, Brinkmalm, Gunnar, Rosa Neto, Pedro, Blennow, Kaj

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

    Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected... by Suárez‐Calvet, Marc, Karikari, Thomas K, Ashton, Nicholas J, Lantero Rodríguez, Juan, Milà‐Alomà, Marta, Gispert, Juan Domingo, Salvadó, Gemma, Minguillon, Carolina, Fauria, Karine, Shekari, Mahnaz, Grau‐Rivera, Oriol, Arenaza‐Urquijo, Eider M, Sala‐Vila, Aleix, Sánchez‐Benavides, Gonzalo, González‐de‐Echávarri, José Maria, Kollmorgen, Gwendlyn, Stoops, Erik, Vanmechelen, Eugeen, Zetterberg, Henrik, Blennow, Kaj, Molinuevo, José Luis

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome

    Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome by Lleó, Alberto, Zetterberg, Henrik, Pegueroles, Jordi, Karikari, Thomas K., Carmona-Iragui, María, Ashton, Nicholas J., Montal, Victor, Barroeta, Isabel, Lantero-Rodríguez, Juan, Videla, Laura, Altuna, Miren, Benejam, Bessy, Fernandez, Susana, Valldeneu, Silvia, Garzón, Diana, Bejanin, Alexandre, Iulita, Maria Florencia, Camacho, Valle, Medrano-Martorell, Santiago, Belbin, Olivia, Clarimon, Jordi, Lehmann, Sylvain, Alcolea, Daniel, Blesa, Rafael, Blennow, Kaj, Fortea, Juan

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: